Loading stock data…
LFST
$7.66+0.32 (+4.36%)
After Hours$7.66+0.00 (+0.00%)· Last close Jun 9
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
LifeStance Health Group, Inc. in the Healthcare sector is trading at $7.66. Wall Street consensus targets $10.55 (10 analysts), implying a +37.7% move over the next 12 months. The stock is currently 14% below its 52-week high of $8.89, remaining 17.3% above its 200-day moving average. On fundamentals, Piotroski 9/9 indicates strong financial quality, Altman Z in the distress zone. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +37.7% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
JNJUNHPFE
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$7.66
Potential Downside
0%
Whystock Fair Value$7.66
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus10 analysts
Buy
Mean target$10.55+37.7%
Range$9.00 – $13.00
Fundamentals
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a multidisciplinary suite of mental health services...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
1.57%
Volume
Today's trading volume
1.76M
Recent News
4 Outpatient Home Health Stocks Benefiting From Industry Trends
An aging population and rising telehealth and AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, LFST and AVAH stand to benefit.
Assessing LifeStance Health Group (LFST) Valuation After Recent Share Price Momentum
Event context and recent share performance LifeStance Health Group (LFST) has been on investors’ radar after recent share price moves, with the stock up 3% over the past day, 7% over the past week, and 5% over the past month. See our latest analysis for LifeStance Health Group. Beyond the recent uptick, LifeStance Health Group’s share price return of 14.08% year to date and 9.22% over 90 days sits alongside a 1 year total shareholder return of 35.03%. This suggests momentum has been building...
1 Healthcare Stock with Promising Prospects and 2 We Find Risky
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have caused the industry to lag recently - over the past six months, the collective 3.8% gain for healthcare stocks has fallen short of the S&P 500’s 10.9% rise.
Wall Street Analysts Predict a 37.26% Upside in LifeStance Health (LFST): Here's What You Should Know
The average of price targets set by Wall Street analysts indicates a potential upside of 37.3% in LifeStance Health (LFST). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Bears are Losing Control Over LifeStance Health (LFST), Here's Why It's a 'Buy' Now
After losing some value lately, a hammer chart pattern has been formed for LifeStance Health (LFST), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.